Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-25 @ 3:31 AM
Ignite Modification Date:
2025-12-25 @ 3:31 AM
NCT ID:
NCT06711705
Brief Title:
Elranatamab in Relapsed/Refractory Multiple Myeloma
Official Title:
Phase II MRD-Adapted Study of Elranatamab in Relapsed/Refractory
Study:
NCT06711705
Protocol Section:
NCT06711705